Nuvation Bio Inc.

NYSE:NUVB

2.68 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 0.7271.43500.2640000000000000000000
Cost of Revenue 1.5151.5910.0580.0550.0550.0380.0390.1060.2170.1140.0470.0430.070.0410.0300000000
Gross Profit -0.788-0.156-0.0580.209-0.055-0.038-0.039-0.106-0.217-0.114-0.047-0.043-0.07-0.041-0.0300000000
Gross Profit Ratio -1.084-0.10900.7920000000000000000000
Reseach & Development Expenses 27.73129.24712.84215.35118.56118.5918.78716.87121.29428.92220.72922.00217.12214.03415.8799.3368.6277.3457.2958.84.0366.1356.135
General & Administrative Expenses 015.6567.3575.487.7787.5417.7347.4648.0448.9487.4637.6075.6696.44.6054.4322.9191.6721.9251.6311.2291.8671.867
Selling & Marketing Expenses 00.256-0.058-0.0550000000000000000.190.2100
SG&A 19.58215.9127.2995.4257.7787.5417.7347.4648.0448.9487.4637.6075.6696.44.6054.4322.9191.6721.9251.8211.4391.8671.867
Other Expenses 0-0.247-0.265-0.26-0.228-0.231-0.23-0.225-0.263-0.215-0.169-0.19-0.17-0.176-0.108-0.103-0.052-0.056-0.060000
Operating Expenses 47.31345.15920.14120.77626.33926.13126.52124.33529.33837.8728.19229.60922.79120.43420.48413.76811.5469.0179.2210.6445.538.0048.004
Operating Income -48.101-45.315-20.199-20.831-26.339-26.131-26.521-24.335-29.338-37.87-28.192-29.609-22.791-20.434-20.484-13.768-11.546-9.017-9.22-10.621-5.475-8.002-8.002
Operating Income Ratio -66.164-31.5780-78.9050000000000000000000
Total Other Income Expenses Net 6.8917.8935.4077.0446.695.4914.7953.492.1353.0126.8994.4750.8121.1010.0820.4880.5120.4180.4740.610.566-1.315-1.315
Income Before Tax -41.21-462.492-14.792-13.787-19.649-20.64-21.726-20.845-27.203-34.858-21.293-25.134-21.979-19.333-20.402-13.28-11.034-8.599-8.746-10.011-4.909-9.316-9.316
Income Before Tax Ratio -56.685-322.2940-52.2230000000000000000000
Income Tax Expense 000.01517.435-6.918-5.722-4.795-13.4-2.135-3.012-6.899-4.475-1.794-2.378-0.272-0.488-1.076-0.892-1.00800-1.315-1.315
Net Income -41.21-462.492-14.792-13.787-19.649-20.64-16.931-7.445-25.068-31.846-14.394-25.134-21.979-19.333-20.402-13.28-11.034-8.599-8.746-10.011-4.909-9.316-9.316
Net Income Ratio -56.685-322.2940-52.2230000000000000000000
EPS -0.15-1.89-0.068-0.063-0.09-0.094-0.077-0.034-0.11-0.15-0.067-0.12-0.11-0.095-0.12-0.061-0.051-0.04-0.04-0.042-0.022-0.051-0.051
EPS Diluted -0.15-1.89-0.068-0.063-0.09-0.094-0.077-0.034-0.11-0.15-0.067-0.11-0.11-0.095-0.12-0.061-0.051-0.04-0.04-0.042-0.022-0.051-0.051
EBITDA -41.09-462.116-20.141-20.776-19.594-20.602-26.465-24.286-29.282-37.822-28.146-29.566-22.721-20.393-20.454-13.741-11.52-8.991-9.196-10.613-5.47300
EBITDA Ratio -56.52-31.4080-78.6970000000000000000000